Multi-route administration of immune response modifier compounds

Details for Australian Patent Application No. 2005323024 (hide)

Owner 3M Innovative Properties Company

Inventors Guy, Cynthia A.; Slade, Herbert B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005323024

PCT Pub. Number WO2006/073940

Priority 60/640,873 30.12.04 US

Filing date 28 December 2005

Wipo publication date 13 July 2006

International Classifications

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/073940 Priority application(s): WO2006/073940

26 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323025-Polypeptides that bind BR3 and uses thereof

2005323023-1-(2-methylpropyl)-1H-imidazo[4,5-c][1, 5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1H-imidazo[4,5-c][1, 5]naphthyridin-4-amine methanesulfonate